HealthAllergy

FDA Warns About Severe Itching After Stopping Popular Allergy Medications

about 1 year agoUS
FDA Warns About Severe Itching After Stopping Popular Allergy MedicationsSource: medpagetoday.com
The U.S. Food and Drug Administration (FDA) has issued a warning regarding the potential for "rare but severe itching" (pruritus) in patients who discontinue long-term use of the popular oral allergy medications Zyrtec (cetirizine) or Xyzal (levocetirizine). This warning highlights a previously under-recognized side effect associated with stopping these medications, which are commonly used to treat seasonal allergies.

Key Insights

The FDA reported 209 cases worldwide (197 in the U.S.) of pruritus after halting use of cetirizine or levocetirizine between April 2017 and July 2023.

Patients had typically used these medications daily for at least a few months, and often for years, before experiencing itching upon cessation.

The itching can significantly impact quality of life, in some cases leading to disability, hospitalization, or thoughts of self-harm.

The FDA estimates that in 2022, 26.8 million prescriptions for cetirizine and levocetirizine were dispensed, with an additional 62.7 million over-the-counter (OTC) products purchased.

Why this matters: Millions of Americans rely on Zyrtec and Xyzal to manage allergy symptoms. This new warning provides crucial information for both patients and healthcare providers regarding the potential risks associated with discontinuing these medications after prolonged use.

In-Depth Analysis

The FDA's warning is based on an analysis of adverse event reports indicating a possible causal relationship between stopping cetirizine or levocetirizine and the onset of pruritus. While the exact mechanism behind this phenomenon remains unknown, the agency is requiring manufacturers to add a warning to both prescription and OTC labels.

Background Context:

Cetirizine and levocetirizine are antihistamines that work by blocking histamines released by the body during allergic reactions. Cetirizine was initially approved as a prescription drug in 1995 and became available over the counter in 2007. Levocetirizine was approved for prescription use in 2007 and switched to over-the-counter status in 2017.

How to Prepare:

Individuals planning long-term use of Zyrtec or Xyzal should discuss the benefits and risks with their healthcare provider.

Patients experiencing severe itching after stopping these medications should contact their healthcare provider.

Restarting the medication or tapering off the dose after restarting may help resolve the itching.

FAQs

Q: What should I do if I experience itching after stopping Zyrtec or Xyzal?

Contact your healthcare provider for guidance. Restarting the medication or tapering off the dose may alleviate symptoms.

Q: Is this a common side effect?

The FDA considers this to be a rare side effect, especially compared to how often the medications are used.

Key Takeaways

The FDA has issued a warning about the potential for severe itching after stopping long-term use of Zyrtec and Xyzal.

This itching may require medical intervention and can significantly impact quality of life.

If you are planning to use these medications long-term, discuss the risks and benefits with your healthcare provider.

Discussion

Do you think this new warning will change how people use these allergy medications? Share this article with others who need to stay ahead of this trend!

⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer